Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Dr Reddy’s Laboratories ( (RDY) ) is now available.
On February 4, 2025, Dr. Reddy’s Laboratories announced its participation in upcoming investor conferences organized by Avendus SPARK in Mumbai on February 10 and 11, 2025. These meetings, conducted in person, aim to engage with institutional investors and provide insights into the company’s strategies and operations. This engagement reflects Dr. Reddy’s proactive approach to maintaining transparency and fostering investor relations, which is crucial for its market positioning and stakeholder engagement.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is a prominent pharmaceutical company based in Hyderabad, India. The company is known for its production of generic medications and pharmaceutical ingredients, with a strong focus on the global healthcare market.
YTD Price Performance: -11.81%
Average Trading Volume: 1,574,767
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.73B
See more data about RDY stock on TipRanks’ Stock Analysis page.
